Related Experiment Video

Updated: Jul 13, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Fungal malformins inhibit bleomycin-induced G2 checkpoint in Jurkat cells

Keiichi Hagimori1, Takashi Fukuda, Yoko Hasegawa

  • 1Kitasato Institute for Life Sciences & Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan.

Biological & Pharmaceutical Bulletin
|August 2, 2007
PubMed

Insights

Malformin C, a fungal cyclopeptide, disrupts the G2 cell cycle checkpoint in cancer cells, sensitizing them to DNA-damaging agents like bleomycin. This compound shows promise in cancer therapy research.

Area of Science:

  • Cell Biology
  • Molecular Pharmacology
  • Cancer Research

Background:

  • Bleomycin induces G2 cell cycle arrest in Jurkat cells.
  • Colchicine induces M phase arrest in Jurkat cells.
  • Cancer cells often have cell cycle checkpoint defects.

Purpose of the Study:

  • To investigate the effect of fungal cyclopeptides, malformin A1 and malformin C, on cell cycle arrest.
  • To determine if malformins can abrogate bleomycin-induced G2 arrest.
  • To assess the impact of malformins on colchicine-induced M phase arrest.

Main Methods:

  • Cell cycle analysis of Jurkat and HCT-116 cells.
  • Treatment with bleomycin, colchicine, malformin A1, and malformin C.
  • Determination of half-maximal inhibitory concentrations (IC50).

Main Results:

  • Malformin A1 and C abrogated bleomycin-induced G2 arrest in Jurkat cells.
  • Malformin C also abrogated bleomycin-induced G2 arrest in HCT-116 cells.
  • Malformins had minimal effect on colchicine-induced M phase arrest.

Conclusions:

  • Malformin C disrupts the G2 checkpoint in cancer cells.
  • Malformin C sensitizes cancer cells to DNA-damaging agents.
  • Malformin C holds potential as a sensitizing agent in cancer therapy.

More Related Videos

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...